Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058145) titled 'Investigation of the Immunomodulatory Effects of Continuous Consumption of the Test Supplement - A Randomized, Double-Blind, Parallel-Group Comparative Trial' on Oct. 12.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - IMEQRD Co., Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effects of 12 weeks of test supplement consumption on immune function in men and women age...